DexCom Inc (DXCM)
128.38
+1.76
(+1.39%)
USD |
NASDAQ |
May 03, 16:00
128.38
0.00 (0.00%)
After-Hours: 18:05
DexCom Cash from Operations (Quarterly): 209.20M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 209.20M |
| December 31, 2023 | 133.60M |
| September 30, 2023 | 269.20M |
| June 30, 2023 | 190.30M |
| March 31, 2023 | 155.40M |
| December 31, 2022 | 132.50M |
| September 30, 2022 | 293.20M |
| June 30, 2022 | 172.80M |
| March 31, 2022 | 71.00M |
| December 31, 2021 | 105.80M |
| September 30, 2021 | 247.30M |
| June 30, 2021 | 61.60M |
| March 31, 2021 | 27.80M |
| December 31, 2020 | 172.00M |
| September 30, 2020 | 147.60M |
| June 30, 2020 | 154.10M |
| March 31, 2020 | 1.90M |
| December 31, 2019 | 143.70M |
| September 30, 2019 | 94.50M |
| June 30, 2019 | 64.50M |
| March 31, 2019 | 11.80M |
| December 31, 2018 | 33.70M |
| September 30, 2018 | 56.80M |
| June 30, 2018 | 41.40M |
| March 31, 2018 | -8.70M |
| Date | Value |
|---|---|
| December 31, 2017 | 41.20M |
| September 30, 2017 | 36.20M |
| June 30, 2017 | 14.30M |
| March 31, 2017 | 0.30M |
| December 31, 2016 | 13.30M |
| September 30, 2016 | 23.00M |
| June 30, 2016 | 20.10M |
| March 31, 2016 | -0.20M |
| December 31, 2015 | 11.30M |
| September 30, 2015 | 17.90M |
| June 30, 2015 | 16.40M |
| March 31, 2015 | 3.40M |
| December 31, 2014 | 8.40M |
| September 30, 2014 | 11.40M |
| June 30, 2014 | 6.20M |
| March 31, 2014 | -2.40M |
| December 31, 2013 | 4.40M |
| September 30, 2013 | 1.60M |
| June 30, 2013 | 0.90M |
| March 31, 2013 | -4.50M |
| December 31, 2012 | -10.60M |
| September 30, 2012 | -6.00M |
| June 30, 2012 | -6.30M |
| March 31, 2012 | -10.20M |
| December 31, 2011 | -11.54M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
1.90M
Minimum
Mar 2020
293.20M
Maximum
Sep 2022
142.40M
Average
145.65M
Median
Cash from Operations (Quarterly) Benchmarks
| Edwards Lifesciences Corp | -53.50M |
| Abbott Laboratories | 3.038B |
| Cardinal Health Inc | 1.189B |
| Intuitive Surgical Inc | 265.40M |
| Insulet Corp | 45.20M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 74.80M |
| Cash from Financing (Quarterly) | 4.70M |
| Free Cash Flow | 583.50M |
| Free Cash Flow Per Share (Quarterly) | 0.3655 |
| Free Cash Flow to Equity (Quarterly) | 150.50M |
| Free Cash Flow to Firm (Quarterly) | 152.30M |
| Free Cash Flow Yield | 1.07% |